OSCR Oscar Health, Inc. Class A Common Stock
Über Oscar Health, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
Mehr lesen
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
OSCR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
OSCR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
OSCR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 2 10,5%
- Kauf 7 36,8%
- Halten 9 47,4%
- Verkauf 1 5,3%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $1.10 | $0.39 | 0.71% |
| 31. März 2026 | $2.07 | $1.21 | 0.86% |
| 31. Dezember 2025 | $-1.24 | $-0.91 | -0.33% |
| 30. September 2025 | $-0.53 | $-0.57 | 0.04% |
| 30. Juni 2025 | $-0.89 | $-0.47 | -0.42% |
| 31. März 2025 | $0.92 | $0.81 | 0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OSCR | — | -8.5 | 27.5% | -3.8% | -44.5% | — |
| PRU | — | — | — | — | — | — |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | — |
| UNM | — | — | — | — | — | — |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | — |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | — |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | — |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | — |
| GNW | $3.54B | 16.7 | 0.08% | 3.0% | 2.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
Bewertung (TTM) 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | -503,695,000 | 259,273,000 | 255,531,000 | 251,279,000 | -472,835,000 | 243,106,000 | 238,672,000 | 231,443,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | -558,354,000 | 259,273,000 | 255,531,000 | 305,938,000 | -575,014,000 | 243,106,000 | 303,965,000 | 293,796,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
Cashflow 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.38B | $13.54B | · | $11.32B | $10.55B | $9.83B | · | $8.23B | $7.32B | $6.57B | · | $5.41B | $4.99B | $4.44B | · | $3.41B | |
| Net Income TTM | $675M | $588M | · | $-145M | $49M | $454M | · | $114M | $153M | $57M | · | $-314M | $-360M | $-420M | · | $-592M | |
| P/E | 16.3 | 7.3 | · | -26.3 | 2144.0 | 8.6 | · | 68.4 | 34.4 | 185.9 | · | -3.8 | -4.8 | -3.3 | · | -1.8 | |
| Earnings Yield | 6.1% | 13.7% | · | -3.8% | 0.05% | 11.6% | · | 1.5% | 2.9% | 0.54% | · | -26.0% | -21.0% | -30.3% | · | -56.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Betriebsgewinnmarge % | -3.4% | 0.62% | -4.0% | — | -29.6% |
| Nettoergebnis | $-443M | $25M | $-271M | $-606M | $-573M |
| Verwässerte EPS | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.3 | 0.4 | — | 0.0 |
| Liquiditätsgrad | 0.9 | 0.8 | 1.3 | — | 1.2 |
| Quick Ratio | 0.6 | 0.6 | 0.8 | — | 0.6 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $1.06B | $950M | $-298M | — | $-208M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 462 Einreicher · $4.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 133 (+65 vs. Vorquartal) | 45 (-20 vs. Vorquartal) | 140 (+17 vs. Vorquartal) | 107 (-3 vs. Vorquartal) | +39.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314.559.172 | 11.029.424 | 7,02% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $301.725.543 | 10.579.437 | 6,73% | Aktien |
| D. E. Shaw & Co., Inc. | $259.880.743 | 9.112.228 | 5,80% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $258.255.502 | 9.055.242 | 5,76% | Aktien |
| Thrive Capital Management, LLC | $180.919.957 | 6.343.617 | 4,04% | Aktien |
| STATE STREET CORP | $165.454.531 | 5.801.351 | 3,69% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162.917.648 | 5.712.400 | 3,64% | Kaufoption |
| GEODE CAPITAL MANAGEMENT, LLC | $141.980.956 | 4.977.203 | 3,17% | Aktien |
| FMR LLC | $138.622.458 | 4.860.535 | 3,09% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $115.097.850 | 4.035.689 | 2,57% | Aktien |
| BIT Capital GmbH | $97.480.134 | 3.417.957 | 2,18% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $94.434.740 | 3.311.177 | 2,11% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $93.673.940 | 3.284.500 | 2,09% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86.282.012 | 3.025.316 | 1,93% | Aktien |
| JANE STREET GROUP, LLC | $74.631.792 | 2.616.823 | 1,67% | Aktien |
| GLYNN CAPITAL MANAGEMENT LLC | $73.462.615 | 2.575.828 | 1,64% | Aktien |
| CITADEL ADVISORS LLC | $72.469.320 | 2.541.000 | 1,62% | Kaufoption |
| WOLVERINE ASSET MANAGEMENT LLC | $61.825.656 | 2.167.800 | 1,38% | Verkaufsoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.458.493 | 2.119.863 | 1,35% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55.351.616 | 1.940.800 | 1,24% | Verkaufsoption |
| JANE STREET GROUP, LLC | $53.968.396 | 1.892.300 | 1,20% | Kaufoption |
| BlackBarn Capital Partners LP | $49.910.000 | 1.750.000 | 1,11% | Verkaufsoption |
| BNP PARIBAS FINANCIAL MARKETS | $48.660.710 | 1.706.196 | 1,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $45.996.029 | 1.612.764 | 1,03% | Aktien |
| CITADEL ADVISORS LLC | $44.459.828 | 1.558.900 | 0,99% | Verkaufsoption |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41.354.000 | 1.450.000 | 0,92% | Aktien |
| BANK OF AMERICA CORP /DE/ | $36.176.793 | 1.268.471 | 0,81% | Aktien |
| Assenagon Asset Management S.A. | $35.592.732 | 1.247.992 | 0,79% | Aktien |
| TWO SIGMA ADVISERS, LP | $35.534.136 | 2.472.800 | 0,79% | Aktien |
| JANE STREET GROUP, LLC | $33.796.200 | 1.185.000 | 0,75% | Verkaufsoption |
| GROUP ONE TRADING LLC | $32.744.154 | 1.148.112 | 0,73% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31.200.652 | 1.093.992 | 0,70% | Aktien |
| Qube Research & Technologies Ltd | $30.913.940 | 1.083.939 | 0,69% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $29.055.948 | 1.018.792 | 0,65% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $28.576.515 | 1.001.982 | 0,64% | Aktien |
| GOLDMAN SACHS GROUP INC | $26.322.819 | 922.960 | 0,59% | Aktien |
| Walleye Capital LLC | $23.243.058 | 814.974 | 0,52% | Aktien |
| Point72 Asset Management, L.P. | $22.809.212 | 799.762 | 0,51% | Aktien |
| Walleye Trading LLC | $22.744.700 | 797.500 | 0,51% | Kaufoption |
| FEDERATED HERMES, INC. | $22.241.550 | 779.858 | 0,50% | Aktien |
| Walleye Trading LLC | $20.594.292 | 722.100 | 0,46% | Verkaufsoption |
| Balyasny Asset Management L.P. | $20.211.240 | 708.669 | 0,45% | Aktien |
| WOLVERINE TRADING, LLC | $19.244.780 | 1.006.000 | 0,43% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $18.292.101 | 641.378 | 0,41% | Aktien |
| Halter Ferguson Financial Inc. | $17.882.240 | 627.007 | 0,40% | Aktien |
| CITADEL ADVISORS LLC | $17.044.921 | 597.648 | 0,38% | Aktien |
| Walleye Trading LLC | $15.952.833 | 559.356 | 0,36% | Aktien |
| Caption Management, LLC | $15.723.076 | 551.300 | 0,35% | Verkaufsoption |
| WOLVERINE TRADING, LLC | $14.846.793 | 776.100 | 0,33% | Verkaufsoption |
| CAPITAL FUND MANAGEMENT S.A. | $14.807.327 | 519.191 | 0,33% | Aktien |
| PFM Health Sciences, LP | $14.802.336 | 519.016 | 0,33% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $14.317.040 | 502.000 | 0,32% | Aktien |
| WELLS FARGO & COMPANY/MN | $14.301.981 | 501.472 | 0,32% | Aktien |
| Eurizon Capital SGR S.p.A. | $13.987.854 | 490.380 | 0,31% | Aktien |
| RPG Investment Advisory, LLC | $13.981.017 | 490.218 | 0,31% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $13.977.652 | 490.100 | 0,31% | Kaufoption |
| Caption Management, LLC | $13.769.456 | 482.800 | 0,31% | Kaufoption |
| Alphabet Inc. | $13.746.298 | 481.988 | 0,31% | Aktien |
| Swiss National Bank | $13.501.368 | 473.400 | 0,30% | Aktien |
| CREDIT AGRICOLE S A | $13.119.286 | 460.003 | 0,29% | Aktien |
| RBF Capital, LLC | $12.822.706 | 449.604 | 0,29% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $12.802.628 | 448.900 | 0,29% | Verkaufsoption |
| Trexquant Investment LP | $12.674.259 | 444.399 | 0,28% | Aktien |
| BlackRock, Inc. | $12.343.114 | 432.788 | 0,28% | Aktien |
| IMC-Chicago, LLC | $12.036.581 | 422.040 | 0,27% | Aktien |
| FORA Capital, LLC | $11.957.021 | 419.030 | 0,27% | Aktien |
| PERCEPTIVE ADVISORS LLC | $11.408.000 | 400.000 | 0,25% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $11.327.203 | 397.167 | 0,25% | Aktien |
| Rhenman & Partners Asset Management AB | $11.179.840 | 392.000 | 0,25% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $10.799.925 | 378.679 | 0,24% | Aktien |
| UBS Group AG | $10.607.358 | 371.927 | 0,24% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $10.027.661 | 351.601 | 0,22% | Aktien |
| ARDSLEY ADVISORY PARTNERS LP | $9.982.000 | 350.000 | 0,22% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $9.924.475 | 347.983 | 0,22% | Aktien |
| Fiduciary Alliance LLC | $9.802.210 | 343.696 | 0,22% | Aktien |
| BCS Private Wealth Management, Inc. | $9.665.000 | 338.885 | 0,22% | Aktien |
| SIMPLEX TRADING, LLC | $9.283.516 | 325.509 | 0,21% | Aktien |
| Squarepoint Ops LLC | $9.166.214 | 321.396 | 0,20% | Aktien |
| SEB Asset Management AB | $9.085.456 | 318.565 | 0,20% | Aktien |
| MARSHALL WACE, LLP | $9.052.762 | 317.418 | 0,20% | Aktien |
| Squarepoint Ops LLC | $8.906.796 | 312.300 | 0,20% | Kaufoption |
| BARCLAYS PLC | $8.827.711 | 309.527 | 0,20% | Aktien |
| Engineers Gate Manager LP | $8.802.185 | 308.632 | 0,20% | Aktien |
| TOWLE & CO | $8.801.186 | 308.597 | 0,20% | Aktien |
| RHUMBLINE ADVISERS | $8.563.598 | 300.267 | 0,19% | Aktien |
| PRUDENTIAL FINANCIAL INC | $8.412.544 | 294.970 | 0,19% | Aktien |
| FIRST TRUST ADVISORS LP | $8.152.727 | 285.860 | 0,18% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.939.968 | 278.400 | 0,18% | Kaufoption |
| FRED ALGER MANAGEMENT, LLC | $7.777.290 | 272.696 | 0,17% | Aktien |
| TORONTO DOMINION BANK | $7.632.066 | 267.604 | 0,17% | Aktien |
| BANK OF MONTREAL /CAN/ | $7.383.828 | 258.900 | 0,16% | Verkaufsoption |
| General Equity Holdings LP | $6.844.800 | 240.000 | 0,15% | Aktien |
| TD Asset Management Inc | $6.561.311 | 230.060 | 0,15% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $6.509.690 | 228.250 | 0,15% | Aktien |
| OSAIC HOLDINGS, INC. | $6.398.318 | 224.346 | 0,14% | Aktien |
| AMERIPRISE FINANCIAL INC | $6.363.383 | 223.120 | 0,14% | Aktien |
| Squarepoint Ops LLC | $6.203.100 | 217.500 | 0,14% | Verkaufsoption |
| Public Sector Pension Investment Board | $6.120.392 | 214.600 | 0,14% | Aktien |
| Bridgewater Associates, LP | $6.094.838 | 213.704 | 0,14% | Aktien |
| NORGES BANK | $5.741.390 | 201.311 | 0,13% | Aktien |
Unternehmensinsider 21 Insider · 10 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 30. Juni 2026 S | 7.751.570 | 1 | 8 | $-58.759.399 |
| Richard Scott Blackley | Chief Financial Officer | 2. Juni 2026 S | 1.074.977 | 0 | 1 | $-493.628 |
| Janet Liang | President, Oscar Insurance | 2. Juni 2026 S | 259.057 | 0 | 1 | $-194.356 |
| Meghan V. Joyce | Chief Operating Officer | 1. September 2021 M | 34.669 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 2. Juni 2026 S | 214.589 | 0 | 1 | $-23.718 |
| Adam Mcananey | Chief Legal Officer | 2. Juni 2026 S | 218.096 | 0 | 1 | $-153.593 |
| Joshua Kushner | Co-Founder and Vice Chairman | 21. November 2024 P | 6.343.617 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 1. September 2021 M | 5.323 | 0 | 0 | $0 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 31. August 2021 A | — | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 5. März 2021 A | 0 | 0 | 0 | $0 |
| William Gassen | Direktor | 9. Juli 2026 A | 82.840 | 0 | 0 | $0 |
| David Plouffe | Direktor | 9. Juli 2026 A | 137.121 | 0 | 0 | $0 |
| Sid Sankaran | Direktor | 9. Juli 2026 A | 22.609 | 0 | 0 | $0 |
| Mario Schlosser | Direktor | 1. Juli 2026 C | 0 | 0 | 16 | $-32.199.014 |
| Laura W Lang | Direktor | 4. Juni 2026 A | 82.840 | 0 | 0 | $0 |
| Vanessa Ames Wittman | Direktor | 4. Juni 2026 A | 137.121 | 0 | 0 | $0 |
| Jeffery H Boyd | Direktor | 9. April 2026 A | — | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | Direktor | 5. März 2021 A | 50.000 | 0 | 0 | $0 |
| Teri List-Stoll | Direktor | 5. März 2021 A | 50.000 | 0 | 0 | $0 |
| Jr Charles E Phillips | Direktor | 5. März 2021 A | 50.000 | 0 | 0 | $0 |
| Ari Fischel | — | 5. März 2021 A | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 Einreichungen | 13. November 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 65 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HEAL · Global X Funds | 4,61% | 51.902 NS | 31. Mai 2026 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 3,73% | 2.476 NS | 30. April 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,79% | 80.448 NS | 30. April 2026 | N-PORT |
| CBSE · Elevation Series Trust | 2,79% | 72.369 NS | 30. April 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 159.618 SH | 8. August 2026 | Täglich |
| RNIN · EA Series Trust | 1,77% | 146.523 NS | 30. April 2026 | N-PORT |
| IAK · iShares Trust | 0,63% | 132.150 SH | 8. August 2026 | Täglich |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,53% | 6.454.468 NS | 31. Mai 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,48% | 132.126 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,40% | 258.034 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,40% | 2.189.278 SH | 8. August 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,37% | 59.569 SH | 8. August 2026 | Täglich |
| OASC · Unified Series Trust | 0,25% | 9.324 NS | 31. Mai 2026 | N-PORT |
| DFVE · DoubleLine ETF Trust | 0,22% | 5.265 NS | 31. März 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,21% | 1.387.125 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,20% | 6.138.237 SH | 8. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 3.171.535 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,19% | 70.748 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 74.299 NS | 30. April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 7.801 NS | 30. April 2026 | N-PORT |
| SMLF · iShares Trust | 0,18% | 282.874 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,18% | 99.887 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,15% | 154.382 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,11% | 87.779 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,11% | 9.555 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,11% | 798.894 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,10% | 1.045.927 NS | 31. Mai 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,10% | 576.130 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,09% | 10.063 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 60.366 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 96.699 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,08% | 5.488.922 SH | 8. August 2026 | Täglich |
| VFH · VANGUARD WORLD FUND | 0,08% | 384.466 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 2.534.194 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,07% | 7.474 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 14.478 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,05% | 7.563 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 5.330 NS | 31. Mai 2026 | N-PORT |
| FNCL · FIDELITY COVINGTON TRUST | 0,04% | 52.605 NS | 30. April 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,04% | 169 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,04% | 9.312 NS | 30. April 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 12.030 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 38.192 NS | 30. April 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,03% | 8.235 NS | 31. Mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,03% | 164.245 NS | 31. Mai 2026 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0,03% | 103.995 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 7.591 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 190 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 416.676 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 18.514 NS | 30. April 2026 | N-PORT |